Levetiracetam in the treatment of infantile spasms

Area of Science:

• Pediatric Neurology
• Epileptology

Background:

• Infantile spasms (IS) are a severe epilepsy syndrome in infants.
• West syndrome, characterized by IS, developmental delay, and hypsarrhythmia on EEG, requires prompt treatment.
• Treatment resistance is common in IS, necessitating exploration of alternative therapies.

Observation:

• An 11-month-old infant presented with a 5-month history of seizures and a 3-month history of infantile spasms.
• Electroencephalogram (EEG) confirmed epileptic encephalopathy.
• The infantile spasms were refractory to clobazam treatment.

Findings:

• Introduction of levetiracetam led to clinical cessation of seizures.
• EEG demonstrated resolution of seizure activity following levetiracetam administration.
• This represents the second reported case of successful IS treatment with levetiracetam.

Implications:

• Levetiracetam shows promise as an effective treatment for infantile spasms, particularly in cases resistant to standard therapies.
• This finding supports further investigation into levetiracetam's role in managing epileptic encephalopathies.
• Early identification and treatment of IS are crucial for improving neurodevelopmental outcomes.